Published in Blood on October 01, 1996
Age and acute myeloid leukemia. Blood (2006) 6.46
PTEN regulation by Akt-EGR1-ARF-PTEN axis. EMBO J (2008) 1.58
Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies. Cancer Res (2009) 1.09
Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies. Proc Natl Acad Sci U S A (2002) 1.08
Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma. Mol Pathol (2000) 1.07
Chromosome 5 allelic losses are early events in tumours of the papilla of Vater and occur at sites similar to those of gastric cancer. Br J Cancer (1998) 0.94
Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes. Ann Hematol (2013) 0.85
PP2A: The Achilles Heal in MDS with 5q Deletion. Front Oncol (2014) 0.79
Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of beta catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy. J Clin Pathol (2005) 0.78
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med (2000) 7.55
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia (2009) 6.29
Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. Proc Natl Acad Sci U S A (1997) 5.61
Transcriptional silencing of Ty1 elements in the RDN1 locus of yeast. Genes Dev (1997) 4.31
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res (2001) 3.66
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib. Leukemia (2008) 3.58
Multiple regulators of Ty1 transposition in Saccharomyces cerevisiae have conserved roles in genome maintenance. Genetics (2001) 3.10
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. J Clin Oncol (2001) 2.71
Localization of gelsolin proximal to ABL on chromosome 9. Am J Hum Genet (1988) 2.64
Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol (1986) 2.64
Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1. Oncogene (2008) 2.31
Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature (1985) 2.25
Studies of the human c-myb gene and its product in human acute leukemias. Science (1986) 2.10
Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). Blood (1989) 1.98
Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood (1993) 1.94
Evidence for two distinct c-src loci on human chromosomes 1 and 20. Nature (1984) 1.91
Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders. Science (1986) 1.91
Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science (1990) 1.90
Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N Engl J Med (1983) 1.86
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. Blood (1999) 1.85
Role of cloned carotenoid genes expressed in Escherichia coli in protecting against inactivation by near-UV light and specific phototoxic molecules. J Bacteriol (1988) 1.84
Prognostic implications of a positive apical margin in radical prostatectomy specimens. J Urol (1997) 1.83
Deletions of interferon genes in acute lymphoblastic leukemia. N Engl J Med (1990) 1.82
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol (2001) 1.79
Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet (2000) 1.78
Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood (1996) 1.77
Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med (1984) 1.76
The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia. Mol Cell Biol (1987) 1.73
Tensor fasciae latae perforator flap for reconstruction of composite Achilles tendon defects with skin and vascularized fascia. Plast Reconstr Surg (2000) 1.57
Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Natl Acad Sci U S A (1993) 1.56
Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (1988) 1.56
Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy. Leukemia (2010) 1.54
Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient. Clin Infect Dis (1993) 1.49
Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders. Proc Natl Acad Sci U S A (1987) 1.47
Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study. Leukemia (2012) 1.44
Evolution of the high molecular weight glutenin loci of the A, B, D, and G genomes of wheat. Genome (1999) 1.44
Therapy-related myeloid leukemia. Hematol Oncol Clin North Am (1996) 1.44
Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev (2001) 1.43
Chimerism does not predict for outcome after alemtuzumab based conditioning. Bone Marrow Transplant (2007) 1.40
[Individual risk-related after-care in colorectal cancer?]. Langenbecks Arch Chir (1991) 1.40
Small intestinal involvement in visceral leishmaniasis. Am J Gastroenterol (1990) 1.39
[Inguinal hernia repair modified by Kirschner. A critical analysis after 11 years of clinical experience]. Langenbecks Arch Chir (1992) 1.39
[Acceptance and effectiveness of surgical vascular consultation--is it worthwhile?]. Chirurg (1995) 1.39
Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia. Br J Haematol (1993) 1.38
Blood vessels of human islets of Langerhans are surrounded by a double basement membrane. Diabetologia (2008) 1.37
Distribution and functional consequences of nucleotide polymorphisms in the 3'-untranslated region of the human Sep15 gene. Cancer Res (2001) 1.35
GAL1-GAL10 divergent promoter region of Saccharomyces cerevisiae contains negative control elements in addition to functionally separate and possibly overlapping upstream activating sequences. Genes Dev (1987) 1.35
Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology. J Biol Chem (2001) 1.32
Clinical practice guidelines on the Internet. A structured, scalable approach. MD Comput (1999) 1.31
t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood (1990) 1.31
Unique basement membrane structure of human pancreatic islets: implications for beta-cell growth and differentiation. Diabetes Obes Metab (2008) 1.28
Association of glutathione S-transferase (GSTM1, T1 and P1) gene polymorphisms with type 2 diabetes mellitus in north Indian population. J Postgrad Med (2010) 1.27
Birds disperse ixodid (Acari: Ixodidae) and Borrelia burgdorferi-infected ticks in Canada. J Med Entomol (2001) 1.26
Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31. Blood (2000) 1.26
A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31. Oncogene (2001) 1.25
Diabetes and ethnic minorities. Postgrad Med J (2005) 1.25
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol (2005) 1.22
Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q). Genomics (2001) 1.22
Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). Blood (1992) 1.21
Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol (1990) 1.20
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol (2001) 1.20
Posttranslational regulation of Ty1 retrotransposition by mitogen-activated protein kinase Fus3. Mol Cell Biol (1998) 1.20
The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia (1989) 1.16
Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood (1987) 1.16
Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. J Urol (1998) 1.16
Evaluation of socio-economic factors causing discontinuation of epilepsy treatment resulting in seizure recurrence: a study in an urban epilepsy clinic in India. Seizure (2007) 1.15
Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood (1993) 1.15
Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer. Genes Chromosomes Cancer (1996) 1.14
Interaction of ustiloxin A with bovine brain tubulin. Biochem Pharmacol (1994) 1.14
Translocation of the p53 gene in t(15;17) in acute promyelocytic leukaemia. Nature (1985) 1.14
Seroprevalence survey of borreliosis in children with chronic arthritis in British Columbia, Canada. J Rheumatol (1992) 1.14
Distribution of vibrios in Calcutta environment with particular reference to V. parahaemolyticus. Indian J Med Res (1977) 1.13
Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival. J Clin Oncol (1997) 1.13
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2007) 1.13
Associations between morphology, karyotype, and clinical features in myeloid leukemias. Hum Pathol (1987) 1.12
Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood (1992) 1.12
Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia. Blood (1987) 1.12
Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival. Urology (2000) 1.11
Purification and characterization of human T-lymphocyte-derived erythroid-potentiating activity. J Biol Chem (1984) 1.11
The Sgs1 helicase of Saccharomyces cerevisiae inhibits retrotransposition of Ty1 multimeric arrays. Mol Cell Biol (2001) 1.10
Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease. Bone Marrow Transplant (2000) 1.09
The uniqueness of being a neurotrophin receptor. Curr Opin Neurobiol (2001) 1.09
Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. Blood (1992) 1.08
Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma? Dis Colon Rectum (1993) 1.07
Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation. Bone Marrow Transplant (2001) 1.07
Outcome of palliative urinary diversion in the treatment of advanced malignancies. Cancer (1999) 1.07
'Golden tongue' syndrome caused by Ramichloridium schulzeri. Arch Dermatol (1985) 1.06
A pilot study of prophylactic aerosolized amphotericin B in patients at risk for prolonged neutropenia. Leuk Lymphoma (1992) 1.06
Synthesis and evaluation of 1,3 di-substituted schiff, mannich bases and spiro isatin derivatives. J Young Pharm (2010) 1.06
Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood (1986) 1.06
The forearm flap. Plast Reconstr Surg (1982) 1.06
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720. Leukemia (2011) 1.05
Treatment of adult acute lymphoblastic leukemia. Semin Oncol (1997) 1.05
Development of a microsatellite genetic map spanning 5q31-q33 and subsequent placement of the LGMD1A locus between D5S178 and IL9. Neuromuscul Disord (1995) 1.04
Urban-rural differences of gynaecological malignancies in Egypt (1999-2002). BJOG (2009) 1.03